Don't Just Read the News, Understand It.
Published loading...Updated

FDA OKs trial of pig livers as dialysis-like treatment for liver failure

  • U.S. researchers will test whether livers from a gene-edited pig could treat people with sudden liver failure by filtering their blood temporarily so their own organ can rest and heal, according to the Food and Drug Administration.
  • The Food and Drug Administration has cleared the first-of-its-kind clinical trial to study this treatment approach.
  • The trial will enroll up to 20 patients who are in intensive-care units and are not suitable for liver transplants.
  • In previous experiments, the pig liver supported some human liver functions for two to three days, according to Mike Curtis, CEO of eGenesis.
Insights by Ground AI
Does this summary seem wrong?
Podcasts & Opinions

47 Articles

All
Left
8
Center
14
Right
4
Center

The xenograft trial will involve 4 patients and will serve to verify if the genetically modified pig liver can be used safely to treat patients with severe organ failure. If the outcome is positive, the idea is to treat up to 20 patients

·Italy
Read Full Article
Rockdale Citizen & Newton CitizenRockdale Citizen & Newton Citizen
Reposted by
Clayton NewsClayton News
Center

New Trial Will Test Gene-Edited Pig Liver for Sudden Liver Failure Patients

Key Takeaways

·Georgia, United States
Read Full Article
Eldiario.esEldiario.es
Reposted by
elDiarioARelDiarioAR
Lean Left

The US authorities have just approved the first clinical trial with pig livers to treat four people with severe liver failure, which is in addition to the first multiple trial with pig kidneys authorized in February, a milestone in this field The first pig liver transplant to a human opens a way to expand the stock of available organs The FDA, the body regulating drugs in the US, has approved the first clinical trial to assess the safety of the …

·Spain
Read Full Article

American researchers will soon test whether the livers of a genetically edited pig could treat people with sudden liver failure, temporarily filtering their blood so that their own organ can rest and perhaps heal. The clinical trial, the first of its kind, has been approved by the Food and Drug Administration, according to the eGenesis pig producer, who announced the measure on Tuesday with his partner OrganOx. It is estimated that 35,000 people…

·Washington, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 54% of the sources are Center
54% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hcplive.com broke the news in on Monday, April 14, 2025.
Sources are mostly out of (0)